TLR4 and COVID-19: Employing the molecular docking and systems network pharmacological strategies to uncover the molecular mechanisms, anti-SARS-CoV2/COVID-19 effects of these potential bioactive molecules could be shown to be altered by key bioactives and some corresponding genes such as MAPK14, ACE, TLR4, and MAPK8.